Since NSD1 is frequently mis-regulated in cancers (Tauchmann & Schwaller, 2021), it is tempting to speculate that metabolic rewiring could cause epigenomic alterations in favor of cancer malignancy. This evidence concerns the gene NSD1 and cancer.